Glen moved to Oxford to join the Conway group in 2021 to take up the challenge of synthesizing phosphatidylinositol 5 phosphate (PI5P) derivatives to investigate the role of PI5Ps in DNA methylation. He then followed Professor Conway across the Atlantic to UCLA in 2023 where he began working on several medchem SAR and target identification projects, looking at anti-metastasis compounds, pain-relief compounds, and degrader compounds. Glen completed his PhD at the University of Glasgow under the supervision of Dr David France where his thesis focussed on targeted protein degradation in bacteria. While writing his thesis, he took up a PDRA position with Dr Emily Draper, scaling up and optimising the synthesis of naphthalene diimides. Prior to his PhD studies, Glen obtained his MChem degree from the University of Aberdeen.